YD Bio Limited Ordinary Shares
public_traded
YD Bio Limited Ordinary Shares is publicly traded on NASDAQ under ticker YDES.
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.